A Rare Presentation of Priapism From Pegylated Filgrastim During Treatment of Urothelial Cancer in an African-American Patient With Sickle Cell Trait.

Nikhita Kathuria-Prakash, Leland Damron, Sandy C Hernandez, Steven D Hart, Alexandra Drakaki

Abstract readCase Reports

In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nikhita Kathuria-PrakashHematology and Medical Oncology, University of California Los Angeles David Geffen School of Medicine, Los Angeles, USA.

Leland DamronMedicine, University of California Los Angeles David Geffen School of Medicine, Los Angeles, USA.

Sandy C HernandezHematology and Medical Oncology, University of California Los Angeles David Geffen School of Medicine, Los Angeles, USA.

Steven D HartPathology and Laboratory Medicine, University of California Los Angeles David Geffen School of Medicine, Los Angeles, USA.

Alexandra DrakakiHematology and Medical Oncology, University of California Los Angeles David Geffen School of Medicine, Los Angeles, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Priapism is a complication of sickle cell disease resulting in organ-threatening vaso-occlusive crisis and has been reported rarely in patients with sickle cell trait. We report a case of a patient with urothelial carcinoma undergoing chemotherapy and growth factor support with pegylated filgrastim with stuttering priapism triggered by pegylated filgrastim. This is the first case reported, to our knowledge, of stuttering priapism triggered by pegylated filgrastim, and we hope to raise awareness of this potentially organ-threatening complication in this vulnerable population.

Indexed as

hemoglobinopathypegylated filgrastimsickle cell traitstuttering priapismvaso-occlusive crisis

Identifiers

PMID40539190

DOI10.7759/cureus.84492

PMCPMC12178588

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.